Prescription-drug misuse remains a serious concern, but the numbers have changed since the original version of this guide. These ten facts update the picture while keeping the focus on youth, overdose, prescribing, psychiatric medication, and treatment. Each figure identifies the population and period it describes.
Explore this guide
Youth and overdose risk
1. 425,000 adolescents reported prescription pain-reliever misuse
SAMHSA’s 2024 NSDUH estimates that 425,000 people aged 12–17, or 1.6%, misused prescription pain relievers in the past year. This updates the older claim about first-time use in 2011.
The prevention issue remains the same: young people may encounter these medicines at home or through friends. Secure storage, appropriate disposal, and an early conversation about medication sharing can reduce opportunities for misuse.
2. 54,045 overdose deaths involved opioids in 2024
Final CDC mortality data record 54,045 opioid-involved deaths in 2024, down from 79,358 in 2023. Opioids include prescription drugs, heroin, and illicit fentanyl; this total is not a count of prescription-drug deaths alone.
The decline is meaningful, but the number remains substantial. Overdose prevention needs to address both prescribed medicines and the unregulated supply, including pills sold as prescription medication.
3. Fentanyl is approximately 50 times as potent as heroin
The DEA’s fentanyl fact sheet describes its analgesic potency as approximately 50 times that of heroin and 100 times that of morphine. Pharmaceutical fentanyl has medical uses, while illicitly manufactured fentanyl is a major concern in the illegal drug supply.
Potency and uncertain contents make counterfeit pills particularly dangerous. Appearance does not establish that a pill came from a licensed pharmacy or contains the drug and dose it claims.
4. The 2024 overdose toll averaged about 217 deaths per day
The United States recorded 79,384 drug-overdose deaths in 2024, according to CDC. Dividing by the year’s 366 days gives approximately 217 deaths per day. This includes all drugs, rather than prescription medication alone.
The older forecast that female misuse would exceed male misuse within five years is replaced by the observed figures below. For a suspected opioid overdose, give naloxone if available and call 911.
Medication use and prescribing oversight
5. 19.3% of adults took medication for mental health in 2024
The 2024 National Health Interview Survey found that 19.3% of U.S. adults took prescription medication for their mental health in the previous 12 months; 14.0% received counseling or therapy. A person could receive both.
The risk of overreliance on medication is worth discussing in a treatment plan. Ask about the intended benefit, side effects, duration, follow-up, and therapy options. Taking an appropriately prescribed psychiatric medicine is not itself evidence of misuse or addiction.
6. Foster-care prescribing needs careful oversight
The 2011 GAO analysis of 2008 Medicaid data found psychotropic prescribing rates of 22% for foster children in Florida and 39.1% in Massachusetts. These are state-specific historical findings, rather than a current national “one third of all foster children” estimate.
The concern remains current: GAO’s 2024 testimony on youth in residential facilities discusses risks associated with certain prescribing patterns, including multiple psychotropic medicines. Families and caregivers can ask who reviews the medication list, monitors side effects, and provides nonmedication support.
7. Overdose deaths declined for both men and women
In 2024, the age-adjusted overdose death rate was 32.2 per 100,000 for males and 14.1 for females, according to CDC’s final figures. Both declined from 2023. These rates cover overdose deaths involving any drug.
Differences in pain, mental health, caregiving responsibilities, access to care, and drug exposure can affect prevention needs. A person’s symptoms and medication use deserve assessment without assuming that seeking pain relief is evidence of addiction.
8. Nearly half of people used a prescription drug in a month
The CDC’s published therapeutic-drug-use figures report 49.9% using at least one prescription medicine in the previous 30 days and 13.5% using five or more. These nationally representative estimates cover 2017–March 2020.
These figures measure medication use, not daily use or drug misuse. Concerns about overmedication can be addressed through a complete medication review: include medicines from every prescriber, over-the-counter products, and supplements, and ask about unnecessary duplication or interactions.
9. 71.9% of physician-office visits involved drug therapy
In the 2019 National Ambulatory Medical Care Survey, 71.9% of office visits involved medication therapy. This includes medicines provided, prescribed, or continued at a visit; it does not mean every visit produced a new prescription.
Prescribing deserves active follow-up, particularly for medicines with dependence or overdose risks. Patients can ask what improvement to expect, when treatment will be reviewed, which nondrug approaches could help, and how to change a medication safely if it is no longer useful.
Prescription opioid misuse today
National survey / 2023–2024
Prescription-drug misuse by age
Compare the share of each age group reporting misuse. Select a medication group, survey year and recall period.
Prescription opioids · 2024 · past year misuse
US civilian, noninstitutionalized population.
View all chart data and sources
US civilian, noninstitutionalized population. Misuse means use in a way not directed by a doctor, including use without one’s own prescription, in greater amounts or more often, or for longer than directed. These percentages use everyone in the age group as the denominator, not just people who take medication. The all-ages estimate overlaps the age groups. Prescription opioids are distinct from illegally made fentanyl. Standard errors are in percentage points, not confidence intervals; small differences may reflect sampling variability.
| Group / year | Percentage | Uncertainty |
|---|---|---|
| All ages 12+ | 2.6% | Standard error: 0.11 percentage points |
| Ages 12–17 | 1.5% | Standard error: 0.15 percentage points |
| Ages 18–25 | 2.6% | Standard error: 0.23 percentage points |
| Ages 26+ | 2.8% | Standard error: 0.13 percentage points |
| Group / year | Percentage | Uncertainty |
|---|---|---|
| All ages 12+ | 0.7% | Standard error: 0.06 percentage points |
| Ages 12–17 | 0.4% | Standard error: 0.07 percentage points |
| Ages 18–25 | 0.6% | Standard error: 0.11 percentage points |
| Ages 26+ | 0.7% | Standard error: 0.08 percentage points |
| Group / year | Percentage | Uncertainty |
|---|---|---|
| All ages 12+ | 2.9% | Standard error: 0.11 percentage points |
| Ages 12–17 | 2.0% | Standard error: 0.19 percentage points |
| Ages 18–25 | 2.4% | Standard error: 0.17 percentage points |
| Ages 26+ | 3.1% | Standard error: 0.14 percentage points |
| Group / year | Percentage | Uncertainty |
|---|---|---|
| All ages 12+ | 0.7% | Standard error: 0.06 percentage points |
| Ages 12–17 | 0.5% | Standard error: 0.11 percentage points |
| Ages 18–25 | 0.5% | Standard error: 0.08 percentage points |
| Ages 26+ | 0.8% | Standard error: 0.07 percentage points |
| Group / year | Percentage | Uncertainty |
|---|---|---|
| All ages 12+ | 1.4% | Standard error: 0.07 percentage points |
| Ages 12–17 | 0.8% | Standard error: 0.12 percentage points |
| Ages 18–25 | 2.8% | Standard error: 0.21 percentage points |
| Ages 26+ | 1.2% | Standard error: 0.08 percentage points |
| Group / year | Percentage | Uncertainty |
|---|---|---|
| All ages 12+ | 0.4% | Standard error: 0.04 percentage points |
| Ages 12–17 | 0.1% | Standard error: 0.04 percentage points |
| Ages 18–25 | 0.6% | Standard error: 0.09 percentage points |
| Ages 26+ | 0.4% | Standard error: 0.05 percentage points |
| Group / year | Percentage | Uncertainty |
|---|---|---|
| All ages 12+ | 1.4% | Standard error: 0.07 percentage points |
| Ages 12–17 | 0.9% | Standard error: 0.12 percentage points |
| Ages 18–25 | 3.1% | Standard error: 0.23 percentage points |
| Ages 26+ | 1.2% | Standard error: 0.08 percentage points |
| Group / year | Percentage | Uncertainty |
|---|---|---|
| All ages 12+ | 0.4% | Standard error: 0.04 percentage points |
| Ages 12–17 | 0.1% | Standard error: 0.04 percentage points |
| Ages 18–25 | 0.9% | Standard error: 0.14 percentage points |
| Ages 26+ | 0.4% | Standard error: 0.04 percentage points |
| Group / year | Percentage | Uncertainty |
|---|---|---|
| All ages 12+ | 1.6% | Standard error: 0.09 percentage points |
| Ages 12–17 | 0.7% | Standard error: 0.10 percentage points |
| Ages 18–25 | 1.6% | Standard error: 0.16 percentage points |
| Ages 26+ | 1.7% | Standard error: 0.10 percentage points |
| Group / year | Percentage | Uncertainty |
|---|---|---|
| All ages 12+ | 0.5% | Standard error: 0.05 percentage points |
| Ages 12–17 | 0.1% | Standard error: 0.05 percentage points |
| Ages 18–25 | 0.5% | Standard error: 0.09 percentage points |
| Ages 26+ | 0.6% | Standard error: 0.06 percentage points |
| Group / year | Percentage | Uncertainty |
|---|---|---|
| All ages 12+ | 1.7% | Standard error: 0.09 percentage points |
| Ages 12–17 | 0.7% | Standard error: 0.10 percentage points |
| Ages 18–25 | 1.7% | Standard error: 0.14 percentage points |
| Ages 26+ | 1.8% | Standard error: 0.11 percentage points |
| Group / year | Percentage | Uncertainty |
|---|---|---|
| All ages 12+ | 0.4% | Standard error: 0.04 percentage points |
| Ages 12–17 | 0.2% | Standard error: 0.05 percentage points |
| Ages 18–25 | 0.5% | Standard error: 0.07 percentage points |
| Ages 26+ | 0.5% | Standard error: 0.05 percentage points |
10. 7.6 million people reported prescription opioid misuse in 2024
SAMHSA estimates 7.6 million people aged 12 or older misused prescription opioids in 2024. The population percentage fell from 3.0% in 2021 to 2.6% in 2024, so describing misuse as “at an all-time high” is no longer accurate.
Misuse includes taking a medicine without your own prescription or using it in a way not directed by a clinician. Dependence and opioid use disorder need assessment, and treatment can include medication and ongoing support. Do not abruptly stop a long-term prescribed medicine without a plan with the prescriber.